Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics, a Belgian clinical-stage biopharmaceutical company
Dear shareholder,
Dear Madam, Dear Sir,
please find attached our press release.
Best regards
Ackermans & van Haaren
Attachment
![](https://ml-eu.globenewswire.com/media/YTc0ZjQzODUtN2YxMC00Yjk2LWI0MjgtMmQ4NTExYmQ4YTYyLTEwMTM1OTc=/tiny/Ackermans-van-Haaren.png)